Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to anti-PD-163% (26/41)…
September 26, 2025 16:05 ET | Source: Silynxcom Ltd. Netanya, Israel, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE…
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- CLO Virtual Fashion, a global leader in digital garment simulation and the creator…
NEWPORT BEACH, Calif., Sept. 24, 2025 /PRNewswire/ -- HYVE Labs™ and MindHYVE.ai™ proudly announce the global launch of ChironAI™, an…
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…
First MultiVM Blockchain for RWAs: MANTRA becomes the first Layer 1 to natively support both EVM and CosmWasm smart contracts,…
Leiden, The Netherlands – September 15, 2025 – ProteoNic, a leader in premium vector technology for biologics and cell and…
The India Research Advisory Council to help the publisher better engage with and serve researchers in the country NEW DELHI,…
NEW HAVEN, Conn., Sept. 10, 2025 /PRNewswire/ -- XingImaging in partnership with SynuSight Biotech has received funding of $3.84M from…
BENGALURU, India, Sept. 6, 2025 /PRNewswire/ -- The Maharashtra government has extended the deadline for installing High Security Registration Plates (HSRP)…